Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
St. Charles Trading is a global ingredient distributor and supply chain service provider specializing in the food, beverage, and nutraceutical industries. Founded in 1984, the company sources and distributes a diverse portfolio of ingredients, including sweeteners, starches, proteins, and fibers. In 2021, the company was acquired by Barentz, a leading global life science ingredients distributor, to enhance its North American distribution network. St. Charles Trading provides value-added services such as logistics management, quality assurance, and technical support to help clients navigate complex global supply chains. The company operates as a key link in the production of health-focused consumer products and dietary supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St. Charles Trading.